V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20216324 | 20155854 | 1.52 | 56.8 | Curative (C) | 2021-05-28 | 2021-05-28 | IRINOTECAN + MDG + PANITUMUMAB | 2 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101308546 |
| 20216326 | 20155855 | 1.71 | 50.3 | Neo-adjuvant (N) | 2018-09-06 | 2018-09-18 | Sorafenib | 02 | N | SORAFENIB | 100039239 |
| 20216331 | 20155856 | null | 50.2 | Neo-adjuvant (N) | 2020-01-10 | 2020-01-15 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 101736844 |
| 20216332 | 20155857 | 1.88 | 60 | Palliative (P) | 2018-05-22 | 2018-06-22 | Cetuximab + FOLFIRI cycle1 | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 101635347 |
| 20216334 | 20155858 | 1.72 | 84 | null | 2015-09-28 | 2016-04-02 | Oxaliplatin + Raltitrexed | null | null | OXALIPLATIN + RALTITREXED | 100998294 |
| 20216336 | 20155859 | 1.57 | 70 | Palliative (P) | 2018-05-31 | 2020-05-01 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101549631 |
| 20216338 | 20155860 | 1.69 | null | Palliative (P) | 2021-11-13 | 2022-01-01 | Trial Unspecified | 02 | N | TRIAL | 100013830 |
| 20216340 | 20155861 | 1.85 | 85.3 | Palliative (P) | 2019-01-31 | 2019-06-27 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100582463 |
| 20216344 | 20155862 | 1.6 | 86 | Palliative (P) | 2020-01-03 | 2020-01-09 | EOX | N | N | SORAFENIB | 100975099 |
| 20216345 | 20155863 | 1.72 | 0 | null | 2017-04-16 | 2017-05-14 | CETUXIMAB + IRINOTECAN + MDG | N | N | CETUXIMAB + IRINOTECAN + MDG | 101473051 |
| 20216347 | 20155864 | 1.88 | 59.05 | Palliative (P) | 2017-06-28 | 2017-11-09 | EOX | 02 | N | EOX | 100621833 |
| 20216348 | 20155865 | 1.78 | 73.4 | null | 2017-09-18 | 2018-03-30 | EOX | 2 | N | TRIAL | 100894221 |
| 20216355 | 20155866 | 0 | 64 | null | 2016-09-11 | 2016-09-27 | CAPECITABINE + RT | 2 | null | CAPECITABINE + RT | 101220769 |
| 20216359 | 20155867 | 1.55 | 99.8 | null | 2019-01-05 | 2019-01-26 | Capecitabine 35days + RT | N | null | CAPECITABINE + RT | 101786222 |
| 20216366 | 20155868 | 1.59 | 80.4 | Palliative (P) | 2020-07-04 | 2020-07-13 | EOX | 2 | N | EOX | 100161097 |
| 20216372 | 20155869 | 1.58 | 73.1 | null | 2017-03-27 | 2017-04-27 | Oxaliplatin + Raltitrexed | 2 | null | OXALIPLATIN + RALTITREXED | 101182407 |
| 20216373 | 20155870 | 1.49 | 54.7 | Palliative (P) | 2017-04-09 | 2017-04-20 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100298894 |
| 20216374 | 20155871 | 1.7 | 73.4 | Palliative (P) | 2017-04-12 | 2018-05-23 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100658648 |
| 20216376 | 20155872 | 1.85 | 66.5 | Adjuvant (A) | 2020-09-02 | 2020-09-02 | Sorafenib | 02 | N | SORAFENIB | 101759653 |
| 20216378 | 20155873 | 1.7 | 83.65 | null | 2020-03-26 | 2020-04-03 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + IRINOTECAN + MDG | 101308670 |
| 20216394 | 20155874 | 1.74 | 36.9 | Neo-adjuvant (N) | 2017-07-14 | 2017-10-24 | EOX | 2 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100348850 |
| 20216395 | 20155875 | 1.75 | 71 | Neo-adjuvant (N) | 2019-01-11 | 2019-01-26 | EOX | N | N | CETUXIMAB + IRINOTECAN + MDG | 101416159 |
| 20216398 | 20155876 | 1.64 | 82 | Neo-adjuvant (N) | 2019-10-07 | 2019-10-22 | EOX | Y | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100901447 |
| 20216401 | 20155877 | 1.83 | 0 | null | 2021-02-06 | 2021-03-03 | EOX | 1 | Y | CETUXIMAB + IRINOTECAN + MDG | 100335388 |
| 20216409 | 20155878 | 1.59 | 76.3 | Palliative (P) | 2017-05-04 | 2017-08-13 | Cetuximab + Oxaliplatin + MdG Maint | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100032003 |
| 20216410 | 20155879 | 1.56 | 51.5 | Palliative (P) | 2017-05-03 | 2017-08-10 | EOX | 02 | N | TRIAL | 101170759 |
| 20216417 | 20155880 | 1.89 | 74.8 | Palliative (P) | 2016-06-03 | 2016-06-04 | EOX | 02 | null | EOX | 100464567 |
| 20216420 | 20155881 | 1.49 | 74.5 | Palliative (P) | 2018-08-29 | 2018-09-21 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100843875 |
| 20216421 | 20155882 | 1.88 | 52 | null | 2018-10-19 | 2018-10-26 | CAPECITABINE + RT | N | null | CAPECITABINE + RT | 101309431 |
| 20216422 | 20155883 | 1.52 | 98 | null | 2019-07-09 | 2019-07-09 | EOX | 02 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100349528 |
| 20216424 | 20155884 | 1.66 | 77.6 | Palliative (P) | 2016-12-10 | 2017-01-25 | Sorafenib | 02 | N | SORAFENIB | 101711579 |
| 20216428 | 20155885 | 1.7 | 80.8 | Palliative (P) | 2019-07-24 | 2019-07-24 | EOX | N | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101114877 |
| 20216430 | 20155886 | 1.76 | 62.8 | Curative (C) | 2019-07-13 | 2021-03-16 | EOX | N | N | EOX | 100430347 |
| 20216432 | 20155887 | 1.72 | 71.1 | Palliative (P) | 2021-07-11 | 2021-07-13 | EOX | N | N | EOX | 101148368 |
| 20216437 | 20155888 | 1.57 | 80.3 | Palliative (P) | 2017-03-05 | 2017-03-07 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100548637 |
| 20216438 | 20155889 | 1.57 | 88.8 | Palliative (P) | 2017-09-04 | 2017-09-04 | EOX | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 100418981 |
| 20216439 | 20155890 | 1.76 | 71.2 | Curative (C) | 2021-07-04 | 2021-07-09 | Sorafenib | 02 | N | SORAFENIB | 100663771 |
| 20216440 | 20155891 | null | 92 | Palliative (P) | null | 2020-01-22 | Sorafenib | 99 | N | SORAFENIB | 101371600 |
| 20216441 | 20155892 | 1.72 | 73.4 | Palliative (P) | 2019-10-14 | 2019-10-15 | EOX | N | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101643539 |
| 20216442 | 20155893 | 1.69 | 88 | Curative (C) | 2019-08-19 | 2019-09-21 | EOX | Y | Y | OXALIPLATIN + RALTITREXED | 101830442 |
| 20216443 | 20155894 | 1.88 | 76 | Palliative (P) | 2020-01-14 | 2020-01-27 | Trial Unspecified | 2 | N | CETUXIMAB + IRINOTECAN + MDG | 101628047 |
| 20216445 | 20155895 | 1.76 | 61.3 | Palliative (P) | 2019-08-02 | 2019-08-17 | EOX | N | N | EOX | 101533868 |
| 20216449 | 20155896 | 1.6 | 0 | Curative (C) | 2019-12-28 | 2020-01-03 | Trial Unspecified | 02 | Y | SORAFENIB | 100648413 |
| 20216450 | 20155897 | 1.71 | 78.2 | Palliative (P) | 2017-08-23 | 2017-09-16 | Oxaliplatin + Raltitrexed | 2 | N | EOX | 101508113 |
| 20216461 | 20155898 | 1.6 | 96.9 | Palliative (P) | 2018-05-08 | 2018-05-25 | Trial Unspecified | 02 | null | TRIAL | 101038626 |
| 20216463 | 20155899 | 1.63 | 100 | Palliative (P) | 2018-12-18 | 2018-12-19 | Cetuximab + Oxaliplatin + MdG Maint | 02 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101021875 |
| 20216465 | 20155900 | 1.81 | 61.2 | Palliative (P) | 2019-02-08 | 2019-02-12 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100552649 |
| 20216469 | 20155901 | 1.72 | 37.9 | Curative (C) | 2016-05-01 | 2017-10-01 | EOX | 02 | Y | OXALIPLATIN + RALTITREXED | 100823395 |
| 20216473 | 20155902 | 1.72 | 95.4 | Palliative (P) | 2018-12-12 | 2019-05-24 | EOX | 99 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101299499 |
| 20216474 | 20155903 | 1.49 | 42.5 | Curative (C) | 2017-05-22 | 2017-05-22 | Sorafenib | 02 | Y | SORAFENIB | 100128197 |